Cleveland BioLabs, Inc. (Nasdaq: CBLI) entered into a strategic research partnership with Roswell Park Cancer Institute to develop the Company's ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE